Literature DB >> 18702750

Medicine and science in the fight against doping in sport.

D H Catlin1, K D Fitch, A Ljungqvist.   

Abstract

The fight against doping in sports commenced as a result of the death of a Danish cyclist during the Rome Olympic Games in 1960. The International Olympic Committee (IOC) established a Medical Commission (IOC-MC) which had the task of designing a strategy to combat the misuse of drugs in Olympic Sport. Some International Sport Federations (IF) and National Sports Federations followed suit, but progress was modest until the world's best male sprinter was found doped with anabolic steroids at the Olympic Games in Seoul in 1988. Further progress was made following the cessation of the cold war in 1989 and in 1999 public authorities around the world joined the Olympic Movement in a unique partnership by creating WADA--the 'World Anti-Doping Agency'. The troubled history of the anti-doping fight from the 1960s until today is reviewed. In particular, the development of detection methods for an ever increasing number of drugs that can be used to dope is described, as are the measures that have been taken to protect the health of the athletes, including those who may need banned substances for medical reasons.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18702750     DOI: 10.1111/j.1365-2796.2008.01993.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  14 in total

Review 1.  Proscribed drugs at the Olympic Games: permitted use and misuse (doping) by athletes.

Authors:  Ken Fitch
Journal:  Clin Med (Lond)       Date:  2012-06       Impact factor: 2.659

Review 2.  Prevalence of doping use in elite sports: a review of numbers and methods.

Authors:  Olivier de Hon; Harm Kuipers; Maarten van Bottenburg
Journal:  Sports Med       Date:  2015-01       Impact factor: 11.136

3.  Attitudes and motivations of competitive cyclists regarding use of banned and legal performance enhancers.

Authors:  Nkaku R Kisaalita; Michael E Robinson
Journal:  J Sports Sci Med       Date:  2014-01-20       Impact factor: 2.988

Review 4.  The diagnostic dilemma of pathological appearance and performance enhancing drug use.

Authors:  Tom Hildebrandt; Justine K Lai; James W Langenbucher; Melanie Schneider; Rachel Yehuda; Donald W Pfaff
Journal:  Drug Alcohol Depend       Date:  2010-11-05       Impact factor: 4.492

5.  Novel serum biomarkers for erythropoietin use in humans: a proteomic approach.

Authors:  Britt Christensen; Lucila Sackmann-Sala; Diana Cruz-Topete; Jens Otto L Jørgensen; Niels Jessen; Carsten Lundby; John J Kopchick
Journal:  J Appl Physiol (1985)       Date:  2010-10-21

6.  Religiousness as a factor of hesitation against doping behavior in college-age athletes.

Authors:  Natasa Zenic; Marija Stipic; Damir Sekulic
Journal:  J Relig Health       Date:  2013-06

7.  Potentially harmful advantage to athletes: a putative connection between UGT2B17 gene deletion polymorphism and renal disorders with prolonged use of anabolic androgenic steroids.

Authors:  Nawed Deshmukh; Andrea Petróczi; James Barker; Andrea D Székely; Iltaf Hussain; Declan P Naughton
Journal:  Subst Abuse Treat Prev Policy       Date:  2010-04-29

Review 8.  Point-of-care diagnostics for niche applications.

Authors:  Brian M Cummins; Frances S Ligler; Glenn M Walker
Journal:  Biotechnol Adv       Date:  2016-02-01       Impact factor: 14.227

9.  A unifying review of bioassay-guided fractionation, effect-directed analysis and related techniques.

Authors:  Michael G Weller
Journal:  Sensors (Basel)       Date:  2012-07-04       Impact factor: 3.576

10.  Characteristics of drug and dietary supplement inquiries by college athletes.

Authors:  Peter J Ambrose; Candy Tsourounis; Rachel Olander; Frank Uryasz
Journal:  Sports Health       Date:  2010-01       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.